The use of long hormonal contraceptives can disrupt the balance of estrogen in the body, resulting in abnormal cell changes. This study aimed to determine a correlation between the duration of hormonal contraception and risk of cervical cancer. This study used a case-control design. The population were patients who had examined at a cancer installation and obstetrics-gynecology polyclinic Dr. Sardjito Hospital in 2018. Case samples were 95 women have cervical cancer diagnosis and control were 95 women with a negative pap smear. Sampling with random sampling. Dependent variable cervical cancer and independent variable the duration of hormonal contraception are obtained from medical records. Cervical cancer is assessed by doctor’s diagnosis. Data analysis used logistic regression. Results showed that 44.7% of samples used long-term hormonal contraception (over 5 years). Length of use of hormonal contraception had a significant correlation with the incidence of cervical cancer (p-value < 0.01). Hormonal contraceptive use more than 5 years have a risk 4.2 times (95% CI 1.01-5.69) of cervical cancer than using less than 5 years after being controlled with the first marriage age and parity
hormonal contraception duration cervical cancer risk, long-term hormonal contraceptive use cervical cancer case-control, estrogen imbalance hormonal contraceptives abnormal cell changes cervix, oral contraceptive pill cervical cancer risk factor, hormonal contraception more than five years cancer risk, contraceptive duration cervical cancer parity marriage age, case-control study hormonal contraception cervical cancer hospital, pap smear cervical cancer hormonal contraceptive users, estrogen disruption contraceptive side effects cervical pathology, logistic regression hormonal contraception cervical cancer risk
DOI 10.21109/kesmas.v14i1.2713 10.21109/kesmas.v14i1.2713
Cite this article
Kusmiyati, Y., Prasistyami, A., Wahyuningsih, H. P., Widyasih, H., & Adnani, Q. E. S. (2019). Duration of Hormonal Contraception and Risk of Cervical Cancer. *Kesmas: National Public Health Journal*, *14*(1). https://doi.org/10.21109/kesmas.v14i1.2713
Kusmiyati Y, Prasistyami A, Wahyuningsih HP, Widyasih H, Adnani QES. Duration of Hormonal Contraception and Risk of Cervical Cancer. Kesmas: National Public Health Journal. 2019;14(1). doi:10.21109/kesmas.v14i1.2713
Kusmiyati, Yuni, et al. "Duration of Hormonal Contraception and Risk of Cervical Cancer." *Kesmas: National Public Health Journal*, vol. 14, no. 1, 2019.
Objective: Hormonal contraceptive use has been associated with the development of cervical cancer, although inconsistent results are reported on the association with intrauterine device (IUD) use. The...
Contraception/Comparison > Oral Contraceptives > Cancer RiskContraception/Comparison > Intrauterine Devices > Cervical Neoplasia RiskGeneral OB/GYN > Cervical Health > Cervical Cancer Risk Factors
Ichida M et al., 2015
Open Access
Asian Pacific Journal of Cancer Prevention : APJCP
Background: Low-dose oral contraceptives (OC) were approved by the Japanese Ministry of Health, Labor and Welfare in 1999, yet despite their contraceptive and non-contraceptive health benefits, only 5...
Contraception/Comparison > Oral Contraceptives > Cancer RiskGeneral OB/GYN > Breast Health > Breast Cancer Risk FactorsResearch Methodology > Study Design > Case-Control Studies
Objective: To assess the risk of oral contraceptives on the occurrence of cervical cancer. Material and Method: A hospital-based case-control study was conducted. Sixty women patients with histologica...
OBJECTIVE: To identify and test the predictive power of potential independent risk factors of postpartum depressive symptoms during pregnancy and the perinatal period.
METHODS: We conducted a case-co...
Postpartum > Mental Health > Postpartum Depression Risk FactorsPregnancy > Complications > Predictors of Adverse OutcomesResearch Methodology > Study Design > Case-Control Studies